MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion

Nature Medicine

Volumn 19, Issue 7, 2013, Pages 892-900

  Soh, James ^a,b   Iqbal, Jahangir ^b   Queiroz, Joyce ^b   Fernandez Hernando, Carlos ^c   Hussain, M Mahmood ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; LIPID; LIPOPROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 30C; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN DIET;

ANIMALS; ATHEROSCLEROSIS; CARRIER PROTEINS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DOWN-REGULATION; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOGENESIS; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS;

MUS;

EID: 84880288761     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3200     Document Type: Article

References (43)

1. Heidenreich, P.A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123, 933-944 (2011).
2. Grundy, S.M. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239 (2004).
3. Hussain, M.M. & Pan, X. Clock genes, intestinal transport and plasma lipid homeostasis. Trends Endocrinol. Metab. 20, 177-185 (2009).
4. Hussain, M.M., Fatma, S., Pan, X. & Iqbal, J. Intestinal lipoprotein assembly. Curr. Opin. Lipidol. 16, 281-285 (2005).
5. Hussain, M.M. et al. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr. Opin. Lipidol. 19, 277-284 (2008).
6. Hussain, M.M., Shi, J. & Dreizen, P. Microsomal triglyceride transfer protein and its role in apolipoprotein B-lipoprotein assembly. J. Lipid Res. 44, 22-32 (2003).
7. Hussain, M.M., Rava, P., Walsh, M., Rana, M. & Iqbal, J. Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. (Lond) 9, 14 (2012).
8. Berriot-Varoqueaux, N., Aggerbeck, L.P., Samson-Bouma, M. & Wetterau, J.R. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr. 20, 663-697 (2000).
9. Burnett, J.R. & Watts, G.F. MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? Expert Opin. Ther. Targets 11, 181-189 (2007).
10. Hussain, M.M. & Bakillah, A. New approaches to target microsomal triglyceride transfer protein. Curr. Opin. Lipidol. 19, 572-578 (2008).
11. Cuchel, M. et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356, 148-156 (2007).
12. Samaha, F.F., McKenney, J., Bloedon, L.T., Sasiela, W.J. & Rader, D.J. Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med. 5, 497-505 (2008).
13. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
14. Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
15. Berezikov, E. Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet. 12, 846-860 (2011).
16. Millar, J.S., Cromley, D.A., McCoy, M.G., Rader, D.J. & Billheimer, J.T. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46, 2023-2028 (2005).
17. Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649-653 (2011).
18. Vickers, K.C. et al. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 57, 533-542 (2013).
19. Rayner, K.J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
20. Najafi-Shoushtari, S.H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566-1569 (2010).
21. Marquart, T.J., Allen, R.M., Ory, D.S. & Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA 107, 12228-12232 (2010).
22. Zsigmond, E., Fuke, Y., Li, L., Kobayashi, K. & Chan, L. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro. J. Lipid Res. 39, 1852-1861 (1998).
23. Westerterp, M., de Haan, W., Berbee, J.F., Havekes, L.M. & Rensen, P.C. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J. Lipid Res. 47, 1203-1211 (2006).
24. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853-858 (2001).
25. Lagos-Quintana, M. et al. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739 (2002).
26. Agrawal, R., Tran, U. & Wessely, O. The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development 136, 3927-3936 (2009).
27. Yu, F. et al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29, 4194-4204 (2010).
28. Zaragosi, L.E. et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol. 12, R64 (2011).
29. Karbiener, M. et al. MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2. RNA Biol. 8, 850-860 (2011).
30. Chang, B.H.J. et al. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein low density lipoprotein production in a viable conditional knockout mouse. J. Biol. Chem. 274, 6051-6055 (1999).
31. Khatun, I. et al. Phospholipid transfer activity of MTP promotes assembly of phospholipid-rich apoB-containing lipoproteins and reduces plasma as well as hepatic lipids in mice. Hepatology 55, 1356-1368 (2012).
32. Iqbal, J., Anwar, K. & Hussain, M.M. Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells. J. Biol. Chem. 278, 31610-31620 (2003).
33. Ibrahimi, A. et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274, 26761-26766 (1999).
34. Wu, X., Zhou, M.Y., Huang, L.S., Wetterau, J. & Ginsberg, H.N. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins. J. Biol. Chem. 271, 10277-10281 (1996).
35. Athar, H., Iqbal, J., Jiang, X.C. & Hussain, M.M. A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein. J. Lipid Res. 45, 764-772 (2004).
36. Rava, P., Athar, H., Johnson, C. & Hussain, M.M. Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein. J. Lipid Res. 46, 1779-1785 (2005).
37. Jamil, H. et al. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci. USA 93, 11991-11995 (1996).
38. Sellers, J.A., Hou, L., Athar, H., Hussain, M.M. & Shelness, G.S. A Drosophila microsomal triglyceride transfer protein homolog promotes the assembly and secretion of human apolipoprotein B: implications for human and insect lipid transport and metabolism. J. Biol. Chem. 278, 20367-20373 (2003).
39. Dai, K., Khatun, I. & Hussain, M.M. NR2F1 and IRE1-ß suppress microsomal triglyceride transfer protein expression and lipoprotein assembly in undifferentiated intestinal epithelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 568-574 (2010).
40. Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509 (1957).
41. Stansbie, D., Brownsey, R.W., Crettaz, M. & Denton, R.M. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem. J. 160, 413-416 (1976).
42. Iritani, N., Yamashita, S. & Numa, S. Dietary control of triglyceride and phospholipid synthesis in rat liver slices. J. Biochem. 80, 217-222 (1976).
43. Iqbal, J. et al. Increased intestinal lipid absorption caused by Ire1ß deficiency contributes to hyperlipidemia and atherosclerosis in apolipoprotein E-deficient mice. Circ. Res. 110, 1575-1584 (2012).